Laserfiche WebLink
b. Recitals <br />c. Special Terms and Conditions; <br />d. General Terms and Conditions; <br />e. Attachment 1: Data Use Security and Confidentiality; <br />f. Attachment 2: Data Security Requirements. <br />g. Attachment 3: HCA Small Numbers Standards <br />h. Attachment 4: Certificate of Destruction <br />i. Schedule A: Statement of Work; <br />j. Exhibit A: HCA RFA #2021 HCA42 for Medication for Opioid Use Disorder (MOUD) in Jails <br />Program, dated December 29, 2021; <br />k. Exhibit B: Contractor's Response dated January 20, 2022; and <br />I. Any other provision, term or material incorporated herein by reference or otherwise <br />incorporated. <br />9. This Amendment will be effective July 1, 2022 ("Effective Date"). <br />10. All capitalized terms not otherwise defined herein have the meaning ascribed to them in the Contract. <br />11. All other terms and conditions of the Contract remain unchanged and in full force and effect. <br />The parties signing below warrant that they have read and understand this Amendment and have authority to <br />execute the Amendment. This Amendment will be binding on HCA only upon signature by both parties. <br />CONTRACTOR SIGNATURE <br />PRINTED NAME AND TITLE <br />SME210: <br />DATE SIGNED <br />q -13-A2, <br />HCA SIGNATURE <br />PRINTED NAME AND TITLE <br />DATE SIGNED <br />Washington State <br />Health Care Authority Page 2 HCA Contract No. K5885-1 <br />